High-dose vitamin B12 for at-home prevention and reversal of Alzheimer's disease and other diseases

Townsend Letter for Doctors and Patients, May, 2006 by Joseph G. Hattersley

86. Bland JS. Prev Med Update. January 1995.

87. Yao Y et al. Decline of serum cobalamin levels with increasing age among geriatric outpatients. Arch Fam Med. 1994;3:918-922.

88. West B. Brain function and antacids. Health Alert. 1995;12(4):3-4.

89. Saltzman JR et al. Effect of hypochlorhydria due to omeprazole treatment of atrophic gastritis on protein-bound vitamin B12 absorption. J Amer Coll Nutr. 1994;13(6):584-591.

90. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B-12). Ann Intern Med. 1994;120:311-215.

91. B12 deficiency from drugs. chrisgupta@alumni.uwaterloo.ca. 8/18/2004.

92. Mowat C, Carswell A, Wirz A, McColl KE. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology. 1999;116:813-822.

93. Rogers SA. Interview on Bland JS, Prev Med Update. July 1992.

94. Crane MG. Vitamin B12 studies in total vegetarians. J Nutr Med. 1994;4:419-430.

95. Rogers SA. Letter to Bland JS, Prev Med Update. April 1995.

96. Am J Clin Nutr. 1991;53:695.

97. Gaby AR. Vegetarian source of vitamin B12 (Literature review & commentary brief article). TLDP. May 2003:32.

98. Wyss-Coray T, Mucke L. Ibuprofen, inflammation and Alzheimer disease. Nature Med. 2000;6;9:973-974.

99. Bland JS. Functional Medicine Update. 2004 issues.

100. Sobel E, Davinpour Z, Sulkave R, et al. Occupations with exposure to electromagnetic fields: A possible risk factor for Alzheimer's disease. Amer J Epidemiology. 1995;42;515-524.

101. Sobel E, Dunn M, Davinpour Z et al. Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology. 1996;47:477-1481.

102. Weiner MA. Evidence points to aluminum's link with Alzheimer's disease. TLDP. 1993;124:113.

103. McLachlan DRC, Bergeron C, Smith JE, et al. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology. 1996;46:401-405.

104. Crapper McLachlan DR, Dalton AJ, Kruck TP et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet. 1991;337(8753):1304-1308.

105. Daniels WM, van Rensberg SJ, van Zyl JM et al. Melatonin prevents beta-amyloid induced lipid peroxidation. J Pineal Res. 1998;24(2);78-82.

106. Faaender K, Mielke O, Bertsch T, et al. Homocysteine in cerebral macro-angiography and micro-angiography. Lancet. 1999;353:1586-87.

107. Clarke R, Smith AD, Jobst KA, et al. Folate, vitamin B12, and serum homocysteine levels in confirmed Alzheimer's disease. Arch Neurol. 1998;55:1449-1455.

108. Dommisse JV. Subtle vitamin-B12 deficiency and psychiatry. Op. cit.

109. Deana R, Vicenti E, Donnella, Deana A. Levels of neurotransmitters in the brains of vitamin-B12-deficient rats. Int Jour Vit Nutr Res. 1977;47:119-122.

110. Jope RS. Alzheimer's Disease Review. 1996;1:2-14.

111. Spector R, Cancilla P, Damasio AR. Is idiopathic dementia a regional vitamin-deficiency state? Op. cit.

112. Thieu L. Nghiem, MD, PhD. Interview, 1990.